Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and efficacy of Glofitamab or Mosunetuzumab with gemcitabine plus oxaliplatin in relapsed/refractory B-cell lymphomas (Diffuse L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Diffuse Large B-cell Lymphoma
• High-grade Large B-cell Lymphoma

Drugs mentioned

• Glofitamab (glofitamab)
• Mosunetuzumab (mosunetuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: B-cell Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2024-03-25